Thiopurines and Lymphoma Risk

Thiopurines and Lymphoma Risk

Findings from a subanalysis of eight population studies that formed part of a meta-analysis of 18 cohort studies showed that…

More...
Risk Prediction in CLL

Risk Prediction in CLL

Results from a retrospective, multicentre study showed that through molecular classification of chronic lymphocytic leukaemia (CLL), based on B-cell receptor…

More...
Improved Outcomes in BL

Improved Outcomes in BL

In a prospective multicentre study undertaken in Germany and Poland, adult patients (n = 363) with Burkitt’s lymphoma (BL) received…

More...
DLBCL Treatment in Elderly

DLBCL Treatment in Elderly

A retrospective cohort analysis was undertaken to evaluate real-world treatment patterns and outcomes in elderly patients with diffuse large B-cell…

More...
Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

Healthcare Matters

  • 1
  • 2
  • 3
Prev Next

A Look at Biosimilars: An Update

Much discussion on the topic of biosimilars and the many different aspects that come into play has taken place. We will present an update on our 2013 article on guidelines for the development process and marketing authorisation requirements for biosimilars, as well as an overview of the role of clinical trials, immunogenicity, the impact of glycosylation drift and the naming of biosimilars.

Read more

Chemotherapy-free Regimens: An Evolving …

Over the last few years, a number of therapies have received approval for the treatment of lymphomas that are not traditional chemotherapy. One such treatment is“R2”. It stands for Revlimid (lenalidomide) plus Rituxan/MabThera (rituximab). However, it’s not the only one.

Read more

Hope for Peripheral T-cell Lymphoma

Peripheral T-cell lymphomas (PTCL) are rare and heterogeneous lymphomas comprising numerous histologies. Given the rarity and number of these lymphomas, the tendency has been to group them as one entity. For decades they have been treated in much the same way as B-cell lymphomas using conventional chemotherapy resulting in poor long-term survival.

Read more

 KYN4   facebook2 twitter2 youtube1

Latest Lymphoma News

  • Need for Vitamin D in DLBCL

    The effect of vitamin D deficiency (VDD) in elderly patients with diffuse large B-cell lymphoma (DLBCL) was examined. Patients (n = 359) with pretreatment 25-hydroxyvitamin D3 (25[OH]D3) serum levels from the RICOVER-60 study and 63 patients from the RICOVER-noRTh study were investigated.


    Read more...
  • Viability of GDP in Lymphoma

    This study set out to determine that patients with relapsed or refractory aggressive lymphoma would receive the same benefit from gemcitabine-based therapy as from standard therapy with DHAP (dexamethasone, cytarabine, cisplatin) prior to autologous stem-cell transplantation. 


    Read more...

What's Happening Around the World

  • A Peek at the IWMF

    This is the second in a series of articles examining the work undertaken by patient organisations to help those affected by WM.

    Waldenstrom’s macroglobulinaemia (WM) is a rare, slow growing blood cancer.

    Read more...  
  • A Peek at AIL (Italy)

    For the last 20 years, Maria Rita Grattarola has been involved with the Italian Association against leukemia-lymphoma and myeloma (AIL). Prior to joining AIL, Maria Rita was a business teacher. Initially, she volunteered for AIL and over the 20 years Maria Rita has been involved with the organisation, she has worked in many different areas.

    Read more...  

Research

  • PET-CT and FL

    Findings from a pooled analysis of central scan review in three multicentre studies showed that positron emission tomography/computed tomography (PET-CT) was more accurate than CT scanning when measuring response to first-line therapy in patients with follicular lymphoma (FL).

    Read more...  
  • CV Risk in HL Survivors

    Adults who had Hodgkin lymphoma (HL) as children are at increased risk of treatment-related cardiovascular (CV) events. In this study, 1,187 survivors of HL with a median age of 31.2 years were asked to complete a questionnaire that assessed their exercise behaviour.

    Read more...  

 
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

Global Database Search

IN THE NODE

Updates